Insight: How compounding pharmacies rallied patients to fight regulation

A sign for pharmaceutical compounding company NECC, a producer of the steroid methylprednisolone acetate, is seen in Framingham, MassachusettsNEW YORK (Reuters) – When senators met nearly a decade ago to consider the dangers of pharmacies that mix or alter drugs with little federal oversight, health officials briefed them on some alarming findings about the safety and efficacy of drugs made by these "compounding pharmacies." Dr. …